Literature DB >> 10847765

Reprogramming transcription during the differentiation of precursor CD4+ T cells into effector Th1 and Th2 cells.

M Rincón1, R A Flavell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10847765     DOI： 10.1016/s1286-4579(99)80013-6

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


× No keyword cloud information.
  4 in total

1.  Interleukin-6 promotes the production of interleukin-4 and interleukin-5 by interleukin-2-dependent and -independent mechanisms in freshly isolated human T cells.

Authors:  Irene H Heijink; Edo Vellenga; Peter Borger; Dirkje S Postma; Jan G R de Monchy; Henk F Kauffman
Journal:  Immunology       Date:  2002-11       Impact factor: 7.397

2.  Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.

Authors:  Shannon E Dunn; Shalina S Ousman; Raymond A Sobel; Luis Zuniga; Sergio E Baranzini; Sawsan Youssef; Andrea Crowell; John Loh; Jorge Oksenberg; Lawrence Steinman
Journal:  J Exp Med       Date:  2007-01-29       Impact factor: 14.307

3.  Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.

Authors:  Shannon E Dunn; Sawsan Youssef; Matthew J Goldstein; Thomas Prod'homme; Martin S Weber; Scott S Zamvil; Lawrence Steinman
Journal:  J Exp Med       Date:  2006-02-13       Impact factor: 14.307

4.  Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.

Authors:  Martin S Weber; Thomas Prod'homme; Sawsan Youssef; Shannon E Dunn; Lawrence Steinman; Scott S Zamvil
Journal:  J Neuroinflammation       Date:  2014-02-06       Impact factor: 8.322
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.